|Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial|
JW Denham, A Steigler, DS Lamb, D Joseph, H Mameghan, S Turner, ...
The lancet oncology 6 (11), 841-850, 2005
|Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial|
JW Denham, A Steigler, DS Lamb, D Joseph, S Turner, J Matthews, ...
The lancet oncology 12 (5), 451-459, 2011
|Phyllodes tumor of the breast|
Y Belkacémi, G Bousquet, H Marsiglia, I Ray-Coquard, N Magné, ...
International Journal of Radiation Oncology* Biology* Physics 70 (2), 492-500, 2008
|Validation of a malnutrition screening tool for patients receiving radiotherapy|
ML Ferguson, J Bauer, B Gallagher, S Capra, DRH Christie, BR Mason
Australasian radiology 43 (3), 325-327, 1999
|Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network|
A Omlin, M Amichetti, D Azria, BF Cole, P Fourneret, P Poortmans, ...
The Lancet Oncology 7 (8), 652-656, 2006
|Turning subjective into objective: the BCCT. core software for evaluation of cosmetic results in breast cancer conservative treatment|
MJ Cardoso, J Cardoso, N Amaral, I Azevedo, L Barreau, M Bernardo, ...
The Breast 16 (5), 456-461, 2007
|Long‐term outcome after radiotherapy alone for lymphocyte‐predominant Hodgkin lymphoma: a retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group|
A Wirth, K Yuen, M Barton, D Roos, K Gogna, G Pratt, C MacLeod, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2005
|Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial|
M Dennis, G Mead, J Forbes, C Graham, M Hackett, GJ Hankey, A House, ...
The Lancet 393 (10168), 265-274, 2019
|Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced …|
JW Denham, D Joseph, DS Lamb, NA Spry, G Duchesne, J Matthews, ...
The Lancet Oncology 15 (10), 1076-1089, 2014
|An analysis of the psychometric profile and frequency of anxiety and depression in Australian men with prostate cancer|
CF Sharpley, DRH Christie
Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …, 2007
|Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled …|
JW Denham, A Steigler, C Wilcox, DS Lamb, D Joseph, C Atkinson, ...
The Lancet Oncology 9 (11), 1058-1068, 2008
|A comparison of methods of cosmetic assessment in breast conservation treatment|
DRH Christie, MY O'brien, JA Christie, T Kron, SA Ferguson, CS Hamilton, ...
The Breast 5 (5), 358-367, 1996
|Primary and secondary bone lymphomas|
C Messina, D Christie, E Zucca, M Gospodarowicz, AJM Ferreri
Cancer treatment reviews 41 (3), 235-246, 2015
|Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial|
A Capp, M Inostroza-Ponta, D Bill, P Moscato, C Lai, D Christie, D Lamb, ...
Radiotherapy and oncology 90 (3), 400-407, 2009
|Factors determining esthetic outcome after breast cancer conservative treatment|
MJ Cardoso, J Cardoso, AC Santos, C Vrieling, D Christie, G Liljegren, ...
The breast journal 13 (2), 140-146, 2007
|Understanding the causes of depression among prostate cancer patients: development of the Effects of Prostate Cancer on Lifestyle Questionnaire|
CF Sharpley, V Bitsika, DRH Christie
Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …, 2009
|Pregnancy and radiotherapy: management options for minimising risk, case series and comprehensive literature review|
SA Luis, DRH Christie, A Kaminski, L Kenny, MH Peres
Journal of medical imaging and radiation oncology 53 (6), 559-568, 2009
|Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation|
D Christie, J Denham, A Steigler, D Lamb, S Turner, H Mameghan, ...
Radiotherapy and oncology 77 (2), 117-125, 2005
|Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study)|
MB Ventre, AJM Ferreri, M Gospodarowicz, S Govi, C Messina, D Porter, ...
The oncologist 19 (3), 291, 2014
|Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints …|
JW Denham, C Wilcox, D Joseph, NA Spry, DS Lamb, KH Tai, J Matthews, ...
The Lancet Oncology 13 (12), 1260-1270, 2012